✦ LIBER ✦

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints

✍ Scribed by Standaert, D.G.; Fernandez, H.H.; Odin, P.; Hauser, R.A.; Espay, A.J.; Steiger, M.; Chouinard, S.; Suchowersky, O.; Yakupov, E.; Merikle, E.P.; Robieson, W.Z.; Chatamra, K.; Benesh, J.

Book ID: 123462892
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 76 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.413

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A long-term, open-label study of levodop

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: safety and motor-symptom endpoints

✍ Espay, A.J.; Odin, P.; Fernandez, H.H.; Hauser, R.A.; Standaert, D.G.; Lang, A.E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

2.254 INTERIM RESULTS FROM ONGOING, LONG

2.254 INTERIM RESULTS FROM ONGOING, LONG-TERM, OPEN-LABEL STUDY OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN PATIENTS WITH PARKINSON'S DISEASE AND SEVERE MOTOR FLUCTUATIONS

✍ P. Odin; K. Chatamra; A.J. Espay; D. Standaert; H.H. Fernandez; J. Benesh; W. Ro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Long-term safety and tolerability of rot

Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study

✍ Lawrence W. Elmer; Erwin Surmann; Babak Boroojerdi; Joseph Jankovic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Combining entacapone with levodopa/DDCI

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

✍ M. Onofrj; A. Thomas; F. Vingerhoets; W. Martin; S. Giménez-Roldán; J.-P. Azulay 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 292 KB

Prevalence of cutaneous adverse events a

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

✍ Balak, Deepak MW; Hengstman, Gerald JD; Hajdarbegovic, Enes; van den Brule, Rob 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 260 KB

Long-term management of patients with sy

Long-term management of patients with symptoms of gastro-oesophageal reflux disease – a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting

✍ Å. N. Hansen; R. Bergheim; H. Fagertun; H. Lund; I. Wiklund; B. Moum 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB